Quarterly Result29 May 2026, 01:49 pm
Ipca Labs: FY26 Audited Results, ₹6 Dividend Recommended
AI Summary
Ipca Laboratories Ltd's Board of Directors approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The board recommended a dividend of ₹6 per share (600%) subject to shareholder approval. Mr. Prashant Godha's re-appointment as Executive Director for 5 years was also approved, effective August 16, 2026, subject to shareholder approval. The Board Meeting was held on May 15, 2024, from 11:30 a.m. to 1:45 p.m.
Key Highlights
- Audited financial results (standalone & consolidated) approved for FY26.
- Dividend of ₹6 per share (600%) recommended for FY26.
- Record date for dividend entitlement fixed as August 7, 2026.
- Prashant Godha re-appointed as Executive Director for 5 years, effective August 16, 2026.
- Standalone revenue from operations for FY26 is ₹7,336.75 Crores.
Price Impact
More from IPCALAB